Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126437951 | 12643795 | 1 | I | 20160714 | 20160802 | 20160811 | 20160811 | EXP | FR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-065055 | BRISTOL MYERS SQUIBB | 13.92 | YR | M | Y | 0.00000 | 20160811 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126437951 | 12643795 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 10 MG, QD | 21436 | 10 | MG | TABLET | QD | ||||||
| 126437951 | 12643795 | 2 | SS | FLUOXETINE HYDROCHLORIDE. | FLUOXETINE HYDROCHLORIDE | 1 | Oral | 10 MG, QD | 0 | 10 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126437951 | 12643795 | 1 | Mental disorder |
| 126437951 | 12643795 | 2 | Mental disorder |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126437951 | 12643795 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126437951 | 12643795 | Malaise | |
| 126437951 | 12643795 | Product use issue | |
| 126437951 | 12643795 | Syncope |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126437951 | 12643795 | 1 | 20160622 | 0 | ||
| 126437951 | 12643795 | 2 | 20160622 | 0 |